Sun Pharma gets US FDA nod for the treatment of Neonatal Seizures

Today, Sun Pharmaceutical Industries Limited and Sun Pharma Advanced Research Company Ltd. announced that SEZABY (phenobarbital sodium powder for injection) has received approval from the U.S. Food and Drug Administration (USFDA) for the management of newborn seizures.
“SEZABY is now the first and only medicine in the United States that is expressly approved for the treatment of newborn seizures in term and preterm infants. In Q4FY23, SEZABY is anticipated to be accessible in the United States “said in the release.

SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection.

Shopping Cart
Scroll to Top